Endometriosis: Market Research Report
Phone: +44 20 8123 2220 Fax: +44 207 900 3970
[email protected] https://marketpublishers.com
Phone: +44 20 8123 2220 https://marketpublishers.com
Endometriosis: Market Research Report Date: Pages: Price: ID:
January 10, 2016 160 US$ 4,950.00 EF8E7253A21EN
This report analyzes the worldwide markets for Endometriosis in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 38 companies including many key and niche players such as AbbVie Inc. AEterna Zentaris Inc. Astellas Pharma Inc. AstraZeneca Plc Bayer HealthCare Pharmaceuticals, Inc.
Table of Content I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS Study Reliability and Reporting Limitations Disclaimers Data Interpretation & Reporting Level Quantitative Techniques & Analytics Product Definitions and Scope of Study II. EXECUTIVE SUMMARY 1. INDUSTRY OVERVIEW Endometriosis Statistics Fact Sheet A Quick Market Primer Poor Efficacy and Safety Profiles of Existing Drugs Lead to Unmet Medical Needs Key Endometriosis Drugs on the Market
Table 1. Leading Endometriosis Drugs on the Market (2015): Percentage Market Share Breakdown of Depo Provera, Eligard, Lupron, Visanne, Zoladex, and Others (includes corresponding Graph/Chart) The Pipeline Review Key Endometriosis Drugs in the Pipeline: 2016 Current and Future Analysis Emerging Treatment for Endometriosis & Endometrial Cancer Global Awareness Campaigns and Efforts
Endometriosis: Market Research Report
2
Phone: +44 20 8123 2220 https://marketpublishers.com
2. ENDOMETRIOSIS & ITS TREATMENT – AN OVERVIEW Introduction Occurrence of Endometriosis in Women Causes and Symptoms Causes Estrogen Theory Müllerianosis Theory Retrograde Menstruation Theory Coelomic Metaplasia Theory Hereditary Factors Environmental Factors Dioxin Behavior in the Body Birth Defects Other Causes Symptoms of Endometriosis Reasons for Pain due to Endometriosis Endometriosis and Infertility Kinds of Endometriosis Reproductive Area Endometriosis Uterosacral/Presacral Nerve Endometriosis Cul-de-Sac ('Pouch of Douglas') Endometriosis Gastrointestinal Endometriosis Pleural (lung/chest cavity/diaphragmatic) Endometriosis Urinary Tract (kidneys, ureters, bladder and urethra) Endometriosis Skin Endometriosis Sciatic Endometriosis Stages of Endometriosis Diagnosis of Endometriosis Major Diagnostic Techniques Pelvic Exam Laparoscopy Other Diagnostic Procedures A New Non-invasive Test for the Diagnosis of Endometriosis Endometriosis Markers Counseling of patients Recurrence of Endometriosis Endometriosis & Infertility Miscarriage Endometriosis & Thyroid Autoimmunity Relationship between Endometriosis and Autoimmune Disease Endometriosis & Cancer Associations & Research Centers The Endometriosis Association Endometriosis Research Center 3. TREATMENT OF ENDOMETRIOSIS Endometriosis & Available Treatment Options Endometriosis Treatment: In a Nutshell I. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) II. Hormonal Therapy Gonadotropin Releasing Hormone (Gnrh) Agonists Select Major GnRH-Agonists for Endometriosis Treatment
Endometriosis: Market Research Report
3
Phone: +44 20 8123 2220 https://marketpublishers.com
Lupron, Zoladex and Synarel – The Major Drugs Abbott’s Lupron (Leuprorelin) AstraZeneca’s Zoladex (Goserelin) Pfizer’s Synarel (Nafarelin Acetate) Add-back Medication Progestogens Select Major Progestins for Endometriosis Treatment Combined Oral Contraceptive Pill Danazol and Other Suppressive Steroids Chinese Herbs – More Effective than Danazol or Gestrinone Aromatase Inhibitors III. Non-hormonal Therapy Anti-Angiogenic Agents Selective COX-2 Inhibitors TNF-Alpha Inhibitors IV. Surgical Techniques V. Complementary Therapies Long-term Approach to Pain Lifestyle Modifications Chinese Herbs Treatment for Endometriosis-related Infertility Hormonal Treatment Minimal to Mild Endometriosis Moderate-Severe Endometriosis Surgical Treatment Minimal-Mild Endometriosis Moderate-Severe Endometriosis Treatment for Ovarian Endometriosis Surgical Vs. Medicinal Interventions Medicinal Interventions Advantages Disadvantages Surgery Advantages Disadvantages In-vitro Fertilization Other Treatment 4. SELECT CLINICAL TRIALS/PRODUCT INNOVATIONS & APPROVALS Virexxa Receives FDA Clearance to Proceed to Phase II OBE2109 by ObsEva Receives IND Clearance Galena Biopharma Presents Phase 1/2a Data on Endometrial Cancer Immunotherapies AbbVie and Neurocrine Report Positive Phase 3 Trial Data of Elagolix ValiRx Plc to Begin Endometriosis Clinical Research with its VAL201 Aurobindo Pharma Receives FDA Approval to Market Tablets for Endometriosis Treatment Lumenis to Introduce UltraPulse DUO CO2 laser system and FemTouch Solution Bayer Launches Phase II Trials of vilaprisan for Endometriosis Treatment Nippon Shinyaku Conducts Phase I Evaluation of NS 580 for Endometriosis Therapy Teleflex to Showcase its Surgical Solutions for Endometriosis ValiRx Plc Receives Patent Grant for VAL201 Hologic Launches NovaSure 6mm Endometrial Ablation System Endometriosis Research Foundation Releases Standardized Data Tools ESHRE Develops App for Endometriosis Management
Endometriosis: Market Research Report
4
Phone: +44 20 8123 2220 https://marketpublishers.com
5. RECENT INDUSTRY ACTIVITY Takeda and Roivant Partner to Form Myovant Evotec-Bayer Collaboration Reaches Important Clinical Milestones for Endometriosis Therapy ObsEva and Kissei Pharmaceutical Enter Into Collaboration Agreement for KLH-2109 Aeterna Zentaris Adds New Clinical Site for Endometrial Cancer Therapy Phase 3 Trial VolitionRx Enters Into Collaboration with University of Oxford for Endometriosis Clinical Solution SRI International and Nobelpharma Enter Into Licensing Agreement for SR16234 6. FOCUS ON SELECT GLOBAL PLAYERS AbbVie Inc. (US) AEterna Zentaris Inc. (Canada) Astellas Pharma Inc. (Japan) AstraZeneca Plc. (UK) Bayer HealthCare Pharmaceuticals, Inc. (US) Debiopharm Group (Switzerland) Evotec AG (Germany) Kissei Pharmaceutical Co. , Ltd. (Japan) Neurocrine Biosciences, Inc. (US) ObsEva SA (Switzerland) Pfizer, Inc. (US) Repros Therapeutics, Inc. (US) Roivant Sciences Ltd. (US) Takeda Pharmaceutical Company Limited (Japan) ValiRx Plc (UK) 7. GLOBAL MARKET PERSPECTIVE
Table 2. World Recent Past, Current & Future Analysis for Endometriosis Drugs by Geographic Region US, Canada, Japan, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) Table 3. World Historic Review for Endometriosis Drugs by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) Table 4. World 14-Year Perspective for Endometriosis Drugs by Geographic Region - Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, Asia-Pacific and Rest of World Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart) III. MARKET 1. THE UNITED STATES A. Market Analysis United States: The Largest Market for Endometriosis Endometriosis Associations Increase Awareness Newer Diagnostic Methods Yet to Expand Across the Country Key Endometriosis Drugs on the Market Product Launches Strategic Corporate Developments Select Key Players B. Market Analytics
Endometriosis: Market Research Report
5
Phone: +44 20 8123 2220 https://marketpublishers.com
Table 5. The US Recent Past, Current & Future Analysis for Endometriosis Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) Table 6. The US Historic Review for Endometriosis Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) 2. CANADA A. Market Analysis Product Launch Strategic Corporate Development Select Key Players B. Market Analytics
Table 7. Canadian Recent Past, Current & Future Analysis for Endometriosis Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) Table 8. Canadian Historic Review for Endometriosis Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) 3. JAPAN A. Market Analysis Clinical Trial Select Key Players B. Market Analytics
Table 9. Japanese Recent Past, Current & Future Analysis for Endometriosis Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) Table 10. Japanese Historic Review for Endometriosis Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) 4. EUROPE Market Analysis
Table 11. European Recent Past, Current & Future Analysis for Endometriosis Drugs by Geographic Region/Country - France, Germany, Italy, UK, Spain, and Rest of European Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) Table 12. European Historic Review for Endometriosis Drugs by Geographic Region/Country - France, Germany, Italy, UK, Spain, and Rest of European Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) Table 13. European 14-Year Perspective for Endometriosis Drugs by Geographic Region/Country Percentage Breakdown of Dollar Sales for France, Germany, Italy, UK, Spain, and Rest of European Markets for Years 2009, 2016 and 2022 (includes corresponding Graph/Chart)
Endometriosis: Market Research Report
6
Phone: +44 20 8123 2220 https://marketpublishers.com
4A. FRANCE A. Market Analysis Programmes to Maintain Endometriosis Database B. Market Analytics
Table 14. French Recent Past, Current & Future Analysis for Endometriosis Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) Table 15. French Historic Review for Endometriosis Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) 4B. GERMANY A. Market Analysis Clinical Trial Strategic Corporate Development Evotec Ag – A Key Player B. Market Analytics
Table 16. German Recent Past, Current & Future Analysis for Endometriosis Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) Table 17. German Historic Review for Endometriosis Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) 4C. ITALY Market Analysis
Table 18. Italian Recent Past, Current & Future Analysis for Endometriosis Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) Table 19. Italian Historic Review for Endometriosis Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) 4D. THE UNITED KINGDOM A. Market Analysis Product Launches Select Key Players B. Market Analytics
Table 20. The UK Recent Past, Current & Future Analysis for Endometriosis Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) Table 21. The UK Historic Review for Endometriosis Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) 4E. SPAIN
Endometriosis: Market Research Report
7
Phone: +44 20 8123 2220 https://marketpublishers.com
Market Analysis
Table 22. Spanish Recent Past, Current & Future Analysis for Endometriosis Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) Table 23. Spanish Historic Review for Endometriosis Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) 4F. REST OF EUROPE A. Market Analysis Product Launches Strategic Corporate Developments Select Key Players B. Market Analytics
Table 24. Rest of Europe Recent Past, Current & Future Analysis for Endometriosis Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) Table 25. Rest of Europe Historic Review for Endometriosis Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) 5. ASIA-PACIFIC A. Market Analysis Proteomics Being Researched for Endometriosis Therapeutics (Australia) Select Key Player B. Market Analytics
Table 26. Asia-Pacific Recent Past, Current & Future Analysis for Endometriosis Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) Table 27. Asia-Pacific Historic Review for Endometriosis Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) 6. REST OF WORLD A. Market Analysis Product Launch B. Market Analytics
Table 28. Rest of World Recent Past, Current & Future Analysis for Endometriosis Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2015 through 2022 (includes corresponding Graph/Chart) Table 29. Rest of World Historic Review for Endometriosis Drugs Analyzed with Annual Sales Figures in US$ Million for Years 2009 through 2014 (includes corresponding Graph/Chart) IV. COMPETITIVE LANDSCAPE Total Companies Profiled: 38 (including Divisions/Subsidiaries - 40) The United States (11)
Endometriosis: Market Research Report
8
Phone: +44 20 8123 2220 https://marketpublishers.com
Canada (3) Japan (6) Europe (15) France (1) Germany (3) The United Kingdom (2) Rest of Europe (9) Asia-Pacific (Excluding Japan) (4) Middle-East (1)
Endometriosis: Market Research Report
9
Powered by TCPDF (www.tcpdf.org)
Phone: +44 20 8123 2220 https://marketpublishers.com
I would like to order: Product name: Product link: Product ID: Price:
Endometriosis: Market Research Report https://marketpublishers.com/r/EF8E7253A21EN.html EF8E7253A21EN US$ 4,950.00 (Single User License / Electronic Delivery)
If you want to order Corporate License or Hard Copy, please, contact our Customer Service:
[email protected]
Payment To pay by Credit Card (Visa, MasterCard, American Express, PayPal), please, click 'BUY NOW' button on product page https://marketpublishers.com/r/EF8E7253A21EN.html
To pay by Wire Transfer, please, fill in your contact details in the form below: First name: Last name: E-mail: Company: Address: City: Zip/Post Code: Country: Tel: Fax: Your message:
* All fields are required
Customer Signature _______________________________________ Please, note that by ordering from MarketPublisher.com you are agreeing to our Terms & Conditions at https://marketpublishers.com/docs/terms_conditions.html
To place an order via fax simply print this form, fill in the information below and fax the completed form to +44 20 7900 3970
